ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our previous study on BCR-ABL TKD mutation analysis showed that BCR-ABL mutations accounted for IM resistance in only 21.7% of Malaysian CML patients on IM therapy (communicated separately; in Press).